Signatures of historical demography and pathogen richness on MHC class I genes by Qutob, Nouar
ORIGINAL PAPER
Signatures of historical demography and pathogen
richness on MHC class I genes
Nouar Qutob & Francois Balloux & Towfique Raj &
Hua Liu & Sophie Marion de Procé & John Trowsdale &
Andrea Manica
Received: 13 May 2011 /Accepted: 9 September 2011 /Published online: 23 September 2011
# Springer-Verlag 2011
Abstract The extreme polymorphism of MHC class I has
been argued to be driven by balancing selection from
pathogens, with the prediction that populations exposed to
a wider variety of diseases should have higher diversity. We
assembled a global database of allotype frequencies for
MHC class I genes and investigated possible drivers of
genetic diversity, measured in different ways. We first looked
for a decline in diversity with distance from Africa (a
consequence of drift during human expansions) and then
investigated the link with pathogen richness once the effect
of drift had been corrected for. Using heterozygosity, we
recovered a clear decline in diversity from Africa and
confirmed the positive relationship between genetic diversity
and pathogen richness for all three classical MHC class I
genes. However, when we considered a sequence-based
measure of genetic diversity, the correlation with geographic
distance from Africa vanished for HLA-C, and the
correlations with pathogen richness for the three MHC
class I genes were much weaker. HLA-C is known to
consist of two functional classes of allotypes (classified
with respect to the 80th residue), which interact with
different KIR receptors. While this separation provided
some improvement in the fit between genetic diversity and
distance from Africa for one class, much clearer and
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consistent patterns were recovered when we used the 90th
residue to separate HLA-C allotypes into two new classes.
This suggests that this residue, which is also involved in
the binding of KIR, might have had an important
evolutionary role that has been overlooked.
Keywords MHC .MHC diversity . Dempography .
Pathogen richness . Natural selection
Introduction
The major histocompatibility complex (MHC) genes are
among the most polymorphic genes in vertebrates (Lechler
1994). This diversity has led MHC genes to become one of
the most studied genomic regions from an evolutionary
point of view (reviewed by Piertney and Oliver 2006;
Sommer 2005). Despite this substantial body of work,
what has driven this extraordinary diversity remains
unclear. A number of hypotheses have been put forward
(Apanius et al. 1997), which can be broadly subdivided
into those invoking mate choice and those invoking
selective pressure by pathogens on the immune system.
One of the simplest hypotheses invokes pathogen
driven balancing selection (PDBS), where MHC diversity
is driven by pathogen diversity and the ability of alleles to
recognise different pathogens (Alcaide et al. 2008;
Alcaide et al. 2010; Robinson et al. 2003). Alleles
providing protection against single pathogens have been
described for a variety of diseases (Appanna et al. 2010;
Godot et al. 2000; Guivier et al. 2010; Hill et al. 1991;
Koehler et al. 2010; Meyer and Thomson 2001; Paterson
et al. 1998; Thursz et al. 1995; Trachtenberg et al. 2003),
and it would be advantageous for an individual to carry two
different alleles, as this increases the likelihood of carrying the
right allele when challenged by pathogens (Carrington et al.
1999; Doherty and Zinkernagel 1975; McClelland et al. 2003;
Penn et al. 2002; Thursz et al. 1997). As many pathogens (or
their strains) tend to have limited geographic ranges, this
would further help in explaining the variability of MHC
makeup of different populations worldwide.
A corollary of the PDBS hypothesis is that popula-
tions exposed to a wider variety of infectious diseases
should be characterised by an excess of MHC genetic
diversity once past human demography has been
accounted for. An earlier study put this hypothesis to the
test and confirmed its main prediction on class I MHC
genes, specifically HLA-A, HLA-B and HLA-C, where
HLA stands for the human leukocyte antigen complex. The
study showed that about 17–39% of the variation in MHC
within-population diversity can be explained by the
history of human migrations (i.e. distance from Sub-
Saharan Africa). There was also a significant correlation
with disease burden (measured as a count of the number of
endemic pathogens found in different parts of the world).
While this result is striking, the work only used a crude
measure of genetic diversity, namely, heterozygosity, which
simply considers MHC sequence haplotypes as identical or
different, irrespective of the number and nature of mutations
separating them (Prugnolle et al. 2005b).
Another factor which was not considered is the interplay
between HLA-B and HLA-C and their receptors. HLA-B
and HLA-C proteins are expressed on the surface of
almost all cells and serve as ligands to the products of
the killer immunoglobulin-like receptor (KIR) genes (see
Parham 2005 for a review). KIR receptor genes are
divided into those encoding three domains, KIR3D, and
two domains, KIR2D, respectively. Of the main inhibitory
receptors, KIR3DL1 is a receptor for HLA-B allotypes,
and KIR3DL2 for certain HLA-A allotypes such as HLA-
A*03 and HLA-A*11, whereas KIR2DL1, KIR2DL2 and
KIR2DL3 are specific to HLA-C allotypes (Anfossi et al.
2006; Arnaiz-Villena et al. 2006; Fan and Wiley 1999;
Hansasuta et al. 2004; Hoglund and Brodin 2009; Parham
2005; Single et al. 2007; Thananchai et al. 2007).
HLA-B and HLA-C allotypes can be subdivided into
two functional groups depending on their affinities to
KIR receptors (Rajalingam et al. 2002). HLA-B allotypes
with a Threonine or an Isoleucine at the 80th residue
(Thr80 or Ile80) are known as Bw4, whereas allotypes
with an Asparagine at the same position (Asn80) charac-
terise Bw6 allotypes. The same residue is used to define
HLA-C allotypes, with Asn80 and Lys80 defining the C1
and C2 group allotypes, respectively. Just like MHC, the
KIR gene cluster is highly polymorphic. Specific combi-
nations of MHC and KIR allotypes were found to provide
protection against certain diseases (Boyton and Altmann
2007; Carrington and Martin 2006; Khakoo and Carrington
2006; Rajagopalan and Long 2005; Williams et al. 2005).
KIR2DL1 binds relatively strongly to HLA-C2. KIR2DL3
binds more weakly to HLA-C1 allotypes and a few HLA-
C2. KIR2DL2 binds quite strongly to HLA-C1 as well as to
HLA-C2, but less strongly to the latter (http://www.ebi.ac.
uk/ipd). A small number of HLA-B allotypes such as HLA-
B*46:01 and HLA-B*73:01, with Val76 and Asn80, also
possess the HLA-C1 epitope. At a global level, a negative
correlation between the frequency of activating KIR receptors
and their corresponding HLA ligand groups was observed
(Single et al. 2007). This indicates that MHC and KIR
allotypes are not evolving independently from each other and
that the KIR allotypes should be taken into account when
modelling the distribution of MHC diversity.
In this paper, we expand earlier work on MHC class I
(Prugnolle et al. 2005b). We first repeated the analyses
based on heterozygosity using a larger dataset (roughly
double the populations analysed in the original paper; see
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Fig. 1a–c). We then used sequence-based within-population
genetic diversity measures, which are expected to better
capture the functional differences between allotypes. We
also looked for a coevolutionary signature of KIR and MHC
and alternative subdivisions of allotype families based on
residues involved in KIR binding. Finally, we quantified the
effect of pathogens on the worldwide distribution of genetic
diversity at the class I MHC loci.
Methods
Data sources
We compiled allotype frequencies for MHC class I genes
from the National Center for Biotechnology Information's
MHC database (http://www.ncbi.nlm.nih.gov/gv/mhc) and
the Allele Frequency database (http://www.allelefrequencies.
a
b
c
Fig. 1 Locations of populations
(black dots) for which allotype
frequencies were available for a
HLA-A, b HLA-B and
c HLA-C
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net/). We only considered populations for which complete
amino acid sequences were available [at least four digits in
the HLA code, corresponding to allotypes (see Bodmer et al.
1990 for details), Electronic Supplementary Material (ESM)
Tables 1, 2, 3]. We also checked that allotype frequencies for
each population summed up to one; in the case of
discrepancies, we checked the original publications and
amended the database accordingly. In some cases, the
numbers reported in the literature had been entered incor-
rectly or rounded to the nearest 1/100, which required
adjustment in the database. In other cases, all the values had
been entered correctly, but the sum deviated from unity
because typing failed for a subset of individuals. Such
populations were kept in the database if the sum deviated by
less than 0.05 from 1. Conversely, populations for which we
were unable to find the source for the discrepancy and which
deviated by more than 0.05 from 1 were excluded. Because
the dataset did not include the count of allotypes in each
population, we calculated those by rounding the fractions of
allotypes (computed as the frequencies times the total number
of allotypes) and recalculated the frequencies accordingly.
We limited the analysis to native populations for which we
had a sample size bigger than 30. A large number of
populations were available for all genes: 125 populations
covering 159 HLA-A allotypes, 113 covering 160 HLA-B
allotypes and 93 covering 71 HLA-C allotypes (Fig. 1a-–c
and ESM Tables 1, 2, 3). An unusual problem was presented
by Taiwanese tribes, for which 16 populations were available
from a small geographic area. To avoid over-representing
Taiwanese Natives, we used the average within-population
genetic diversity of all aboriginal Taiwanese samples.
Colonisation routes are difficult to define for Oceanic
populations; for this reason, we repeated all analyses both
including and excluding these populations. Similarly, the
peopling of the Americas has been debated, and so, we
confirmed that all our results are robust to removing these
populations. Since excluding Oceanic or Amerindian popula-
tions never changed qualitatively the results of any analysis,
we present all results including all populations in this paper.
We assigned geographic coordinates to the populations
based on information from the databases or, when this was
lacking, from the original papers. The longitude and
latitude of locations were recovered using spatialepidemi-
ology.net (http://www.spatialepidemiology.net).
We retrieved details about the presence and absence of
diseases in different world populations from the GIDEON
database (http://www.gideononline.com/). The database is
mostly based on World Health Organization statistics. It
provides the user with data on the various infectious
diseases present among world populations. We used a
matrix of the presence and absence of diseases to calculate
the sums of endemic pathogens present in each population.
The pathogens include bacteria, viruses, fungi, macro-
parasites, arthropods and protozoa. We provide a table
giving the presence/absence of pathogens in the populations
used for the analysis (ESM Table 4).
Modeling the effect of ancient demography on MHC
diversity
We considered three measures of genetic diversity giving
different emphasis to sequence variation. The simplest
measure, expected heterozygosity (gene diversity), treats
allotypes as identical or different without taking into
account the number of mutations separating pairs of
sequences (Nei 1978). A more complex approach is to
consider the number of mutations separating each pair of
sequences within a population. If each mutation is
considered as equally likely, the distance between two
sequences can be modelled as a Poisson distribution for
which the mutation rate is drawn from a gamma distribu-
tion. An even more sophisticated approach is to weigh each
mutation differently depending on the likelihood of change
from one amino acid to another. Estimates of transition
likelihoods from a large number of proteins have been
compiled into the so called JTT matrix (Jones et al. 1992).
We used MEGA (Tamura et al. 2007) to first estimate a
pairwise matrix of weighted distances for all amino acids
within each locus, correcting for the heterogeneity in
mutation rates across sites by estimating the appropriate
gamma parameter for each gene using PAML (Yang 1996).
We then used R (R Development Core Team 2005) to
estimate the mean pairwise distance across all pairs of
sequences for each population. Since the Poisson and JTT
diversity measures gave qualitatively similar results, only
the analyses using JTT are presented here.
Neutral genetic diversity shows an incredibly tight link
with geographic distances along landmasses from Sub-
Saharan Africa (Liu et al. 2006; Manica et al. 2007; Prugnolle
et al. 2005b; Ramachandran et al. 2005; Romero et al. 2009).
This has been interpreted as a consequence of the fast
expansion out of Africa 50–70 kyears ago. The remarkable
negative correlations between heterozygosity and distance
from Sub-Saharan Africa (R=−0.93) means that the latter
can be used as a proxy to account for past demographic
history even for populations that have not been typed at
neutral makers. For all the populations in the dataset, we
computed the shortest distances along landmasses from Sub-
Saharan Africa, avoiding mountain regions with average
altitude over 2000 m, using a previously developed
algorithm based on graph theory (Manica et al. 2007;
Manica et al. 2005; Prugnolle et al. 2005a). The hypothetical
origin for anatomically modern humans was set to -12°
latitude and 25° longitude as these coordinates have been
previously shown to represent the best supported origin
based on the analysis of both genetic and morphological data
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(Betti et al. 2009; Manica et al. 2007). For each MHC gene,
we tested the relationship between within-population genetic
diversity (using the three different measures) and geographic
distances from Sub-Saharan Africa.
Important allotype groupings in HLA-B and HLA-C
We also investigated the existence of functional groupings
of allotypes that may have diverged in their sequences due
to differential selective pressures. Coevolution between
HLA-B, HLA-C and KIR genes is relevant in this regard.
The 80th residue of both HLA-B and HLA-C forms part of
the interaction site with KIR (Single et al. 2007).
Accordingly, we split HLA-B into Bw4 and Bw6, and
HLA-C into C1 and C2 (ESM Table 5) and tested the
relationship between genetic diversity and distance from
Africa within each subgroup. Besides considering the split
based on the 80th residue, we also investigated the presence
of any other split based on individual residues known to
interact with KIR (residues 77, 80–83 for HLA-B and 73,
76, 77, 80 and 90 for HLA-C) (Parham 2005; Single et al.
2007), which might improve the fit for sequence-based
diversity vs. distance from Africa in both genes.
Selection by pathogens
We tested for a role of pathogens driving MHC diversity by
examining the relationship between pathogen richness
(total, bacteria or virus) and genetic diversity (using the
different diversity measures) after accounting for the effect
of distance from Africa. To correct for the latter effect, we
first built a linear model with genetic diversity as the
response and distance from Africa and pathogen richness as
predictors. We then dropped pathogen richness from the
model: The decrease in explanatory power (measured in
terms of R2) observed by dropping this factor provided an
estimate of the effect of pathogens above and beyond the
effect that could be attributed to ancient demography (i.e.
distance from Africa).
Results
Relationship between MHC within-population diversity
and geographic distance from Africa
In the first step, we correlated the different measures of
within-population genetic diversity with distance from Sub-
Saharan Africa along landmasses, which is an excellent
proxy for the effect of past demography as testified by the
correlation of over 85% obtained for neutral genetic
markers (Prugnolle et al. 2005b). When considering
heterozygosity, all three genes were characterised by a
progressive loss of diversity with increasing distance from
Africa. These relationships explained between 36% and
41% of the variability in within-population genetic diversity
across the globe (Fig. 2a–c). Using a sequence-based
measure of diversity (JTT) provided a similar pattern for
HLA-A and HLA-B (31.7% and 44.7%, respectively), but
the relationship disappeared for HLA-C (Fig. 2d–f).
While there are several clear outliers, they did not seem
to be over-represented in any particular geographic region.
Moreover, despite the uncertainty about the timing and
routes of the migrations that led to the peopling of Oceania,
there was no obvious difference in the global correlation
when Oceanic populations were included or not, suggesting
that the assumption of simple colonisation routes is
adequate in this context.
Important allotype groupings in HLA-B and HLA-C
HLA-B showed a highly significant relationship between
sequence-based genetic diversity (JTT) and distance from
Africa (Fig. 2e). Dividing the allotypes into two groups
based on their interaction with KIR (Bw4 and Bw6) did not
lead to any improvement in the relationship between JTT
diversity and distance from Africa. Instead, the relationship
was considerably weaker (4.7% and 13.9% for Bw4 and
Bw6, respectively).
As for HLA-C, the correlation between distance from
Africa and sequence-based genetic diversity (JTT) was
particularly low (Fig. 2f). One possible factor which may
obscure the signal of past demography for this gene is its
interaction with its KIR receptors. Thus, we repeated these
analyses on two separate subsets of allotypes. The division
was obtained by splitting all allotypes in two previously
recognised functional subfamilies that show different
relationships to their KIR receptors, namely, C1 and C2.
The division of allotypes based on the 80th residue only led
to a fairly strong negative correlation for the C2 subset
(24.9%), but a further decrease for C1 (1.8%) compared to
when all allotypes were considered together.
As the subdivision in previously recognised functional
families did not lead to a considerable increase in variance
explained by distance from Africa, we also considered
alternative subdivisions of allelic families based on other
residues that are involved in the interaction with KIR.
Classification of HLA-C allotypes into groups that had a clear
demographic signal was successful when we divided all
allotypes into two groups based on the 90th residue
(corresponding to Alanine and Aspartic Acid), but not for any
other position (Table 1). These two groups of allotypes based
on the 90th residue each had a strong relationship between
genetic diversity and distance from Africa (Fig. 3a, b).
Plotting the distribution of these two sets of allotypes revealed
that they are both well represented all over the globe (Fig. 3c).
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We also checked whether there was any subdivision for HLA-
B based on residues other than the 80th residue that would
similarly improve the relationship between diversity and
distance from Africa, but this was not the case (Table 1).
Selection by pathogens
When using heterozygosity as a measure of genetic
diversity, we found the expected positive relationship
between overall pathogen diversity and the residuals of genetic
diversity after correcting for distance from Sub-Saharan Africa
for all three MHC loci (Table 2 and Fig. 4a–c). Subdividing
pathogens into viruses and bacteria revealed that while both
classes of pathogens contribute to the overall pattern, bacteria
had a stronger effect on heterozygosity than viruses. Using
JTT diversity led to most patterns becoming less pronounced,
with the notable exceptions of the link between HLA-C and
viruses and between HLA-B and bacteria (Table 2 and
Fig. 4d–f). Subdividing HLA-C allotypes based on the 90th
residue (the grouping detected previously) showed that the
genetic diversity at the group with an Alanine in the 90th
residue is more correlated to bacterial (R2=6.3%; p=0.019)
and less to viral richness (R2=0.2%; p=0.698). Conversely,
diversity at the group with an Aspartic Acid residue
correlated better with viral (R2=4.5%; p=0.045) than with
bacterial richness (R2=2.3%; p=0.150).
While the results based on heterozygosity are
consistent with previous results, we could not confirm
either of the two trends reported of a higher correlation
with pathogens for HLA-B and of viruses driving the
system.
Discussion
When considering heterozygosity, our results confirmed
previous observations that genetic diversity decreases with
distance from Sub-Saharan Africa, a pattern attributed to a
series of sequential bottlenecks experienced by anatomically
modern humans moving out of Africa 50–60 Kyears ago
(Prugnolle et al. 2005b). This result is also in line with
analyses of other datasets that have shown African popula-
tions to have greater diversity than the rest of the world
(Kidd et al. 2004; e.g. Meyer and Mack 2006). However,
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Fig. 2 Heterozygosity (a)–(c)
and JTT estimates (d)–(f) of
MHC class I genetic diversity
versus distance from
Sub-Saharan Africa. R2
represents the proportion of
explained variance.
***P<0.001; **P<0.01;
*P<0.05. ns non-significant.
Significant relationships are
highlighted in bold
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while our estimates of variance in genetic diversity explained
by distance from Africa are of similar magnitude to the ones
reported on a smaller dataset (Prugnolle et al. 2005b) for
HLA-A (R2=39.6% in this study vs. 39%) and HLA-C (R2=
40.9% vs. 35%), expanding the dataset led to a noticeable
increase for HLA-B (R2=36.2% vs. 17%). Thus, despite
HLA-B having very high overall diversity (Coetzee et al.
2007; McAdam et al. 1994), it seems that, contrary to
previous findings on a smaller dataset, the signature of
ancient demography on this locus is of similar magnitude to
the one observed for the other two MHC class I loci.
Taking into account the number and nature of differences
between allotypes led to a marked deterioration in the
signal of ancient demography on diversity in HLA-C. This
discrepancy between diversity measures suggests that some
MHC allotypes follow different selection patterns. Hetero-
zygosity is a rather crude measure of diversity that is less
sensitive to long-term selection compared to sequence-
based measures of diversity, and it is also less affected by
population bottlenecks (Allendorf 1986). While this lack of
sensitivity could be advantageous if exploring older signals
such as the consequences of the expansion of anatomically
modern humans out of Africa, sequence-based measures of
diversity provide a richer picture of the effects of selective
forces on MHC. The coevolution between MHC and KIR is
an obvious candidate factor which could potentially lead to
the discrepancies among diversity measures observed in this
study. This is supported by the fact that no such discrepancy is
found for HLA-A; most allotypes of which are not ligands for
KIR. Important exceptions include HLA-A*03 and HLA-
A*11 interacting with KIR3DL2 (Hansasuta et al. 2004) and,
in the case of A*11, also with KIR2DS4 (Graef et al. 2009).
In addition, HLA-A*23, HLA-A*24 and HLA-A*32 have a
Bw4 motif and interact with KIR3DL1 (Cella et al. 1994;
Stern et al. 2008).
HLA-C showed the best evidence for coevolution with
KIR shaping worldwide diversity patterns as the C2 group
showed a clear demographic signal, suggesting that the
separation based on the 80th residue accounts for the
confounding selective pressure that obscured this signal
Table 1 Regression analyses for the relationship between distance from Sub-Saharan Africa and genetic diversity of HLA-B and HLA-C
subgroups based on the residues involved in KIR binding
HLA gene Position Residue Number of populations
included in the analysis (N)
A R2 P value
B 77 S 113 198 −10.12%* 0.0015
B 77 N 100 68 −23.89%*** <0.0001
B 77 D 49 9 −1.26% ns 0.8089
B 77 G NA 1 NA NA
B 80 N 113 195 −13.85%** 0.0002
B 80 I 88 45 −10.37%* 0.0027
B 80 T 100 36 1.31% ns 0.28183
B 81 L 113 208 −14.19%*** 0.0001
B 81 A 100 68 −24.46%*** <0.0001
B 82 R 113 194 −12.90%** 0.0003
B 82 L 107 82 −5.52% ns 0.022
B 83 G 113 194 −12.90%** 0.0003
B 83 R 107 82 −5.52% ns 0.0219
C 73 T 93 38 1.16% ns 0.3501
C 73 A 93 34 −24.91%*** <0.0001
C 76 V 93 72 3.8% ns 0.0916
C 77 S 93 40 0.17% ns 0.7203
C 77 N 91 32 −24.72%*** <0.0001
C 80 N 93 40 0.18% ns 0.3500
C 80 K 91 32 −24.93%*** <0.0001
C 90 A 93 46 −13.22%* 0.0012
C 90 D 93 26 −16.74%** 0.0002
Significant relationships are highlighted in bold. The Bonferroni corrected α-value for HLA-B is 0.0042, and for HLA-C, it is 0.0063
A number of allotypes in the subset, R2 proportion of variance explained by geographic distance from Sub-Saharan Africa, ns non-significant, NA
not available
*P<Bonferroni-α; **P<0.001; ***P<0.0001
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when all allotypes were considered. At the same time, we
were unable to recover such a signal from the C1 group.
However, the separation based on the 90th residue gives
two groups each with a clear signal of ancient demography
(i.e. a good negative correlation with distance from Africa),
suggesting that these two groups might have separate
evolutionary histories due to different selective pressures.
There is evidence that the 90th residue affects KIR binding
in addition to the residues 77–83 (Mandelboim et al. 1997;
Stern et al. 2008), suggesting that this residue might have
played an important, yet overlooked, role in the coevolution
between HLA-C and KIR. Mandelboim et al. indicated that
all HLA-C molecules contain either an Alanine at the 73rd
residue cosegregating with an Aspartic Acid at the 90th
residue or Threonine at the 73rd residue cosegregating with
an Alanine at the 90th residue. However, single mutants at
the 73rd residue or the 90th residue affected NK killing
consistent with both positions independently influencing
KIR binding. Interestingly, the dimorphisms at the 73rd
residue and the 90th residue, although showing an
extremely strong allelic association, appear to be segregat-
ing independently of variation that these residues circum-
scribe at the 77th residue and the 80th residue.
It is difficult to predict functional roles of single residues
from genetic data, and other interpretations are possible.
For example, HLA-C*07 is a common HLA-C allotype that
has unusual expression, functional properties and associa-
tion with disease (Kulkarni et al. 2011; Simmonds et al.
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Fig. 3 Relationship between
JTT diversity estimates of
HLA-C allotypes with a an
Alanine and b an Aspartic Acid
in their 90th residue versus
distance from Sub-Saharan
Africa. R2 represents the
proportion of explained
variance. ***P<0.001;
**P<0.01; *P<0.05. ns
non-significant. c Worldwide
distribution of the HLA-C
subgroups based on the 90th
residue (pie charts give the
relative frequency of HLA-C
allotypes with an Alanine in
their 90th in turquoise and the
frequency of HLA-C allotypes
with an Aspartic acid in their
90th residue in red)
Table 2 Proportion of variance (R2) in genetic diversity at MHC class I genes (residuals from the regression against the distance from Sub-
Saharan Africa) explained by pathogen richness (total, as well as split into viruses and bacteria)
Pathogens considered Diversity measure HLA-A (N=125) HLA-B (N=113) HLA-C (N=93)
All pathogens Heterozygosity 9.15%*** 4.25%** 4.76%*
JTT 1.28% ns 1.63% ns 3.18% ns
Viruses Heterozygosity 6.09%*** 2.22% ns 1.13% ns
JTT 0.00% ns 0.33% ns 5.11%*
Bacteria Heterozygosity 4.39%** 6.36%*** 8.67%***
JTT 1.04% ns 5.92%* 5.61%*
Significant relationships are highlighted in bold
N number of populations included in the analysis, ns non-significant
***P<0.001; **P<0.01; *P<0.05
172 Immunogenetics (2012) 64:165–175
2007; Thomas et al. 2009). HLA-C*07 is the strongest
educator of C1-specific NK cells, and it can not be ruled
out at this stage that its dominance skews the data
(Gendzekhadze et al. 2009). Of the major HLA-C allotypes,
only HLA-C*04, HLA-C*06 and HLA-C*07 have an
Aspartic Acid at the 90th residue, and it is possible that
the correlations that we observe are due to a dominant
effect of HLA-C*07. A further possible determinant of
HLA-C diversity that was not explicitly investigated in this
paper is the effect on reproductive fitness caused by the
interaction between certain combinations of haplotypes of
KIR and HLA-C (Gendzekhadze et al. 2001; Hiby et al.
2010; Hiby et al. 2004; Parham and Guethlein 2010). Until
more extensive datasets on the distribution of KIR and
HLA-C haplotypes at the level of the individual become
available, it is not possible to formally investigate this
effect, but it will be interesting to see whether the 90th
residue might play a role in these interactions too.
The significant correlation between disease diversity to
which a population is exposed and its genetic diversity at
MHC class I genes provided further evidence for pathogen-
driven selection, confirming the main findings of a previous
study (Prugnolle et al. 2005b). Genetic diversity was
significantly correlated with overall pathogen diversity for
all three MHC class I loci. This represents an improvement
on the previous analysis on a smaller dataset which had
failed to find a significant relationship for HLA-C. Another
consequence of expanding the dataset was a clear selective
signal not only for viruses but also for bacteria, which only
had a limited effect in the previous analysis. This result is not
unexpected, given that the diversity of the different groups of
pathogens is highly correlated across different countries
(Duhamel and Jacquet 2005; Guernier et al. 2004). While we
find no link between viral richness and genetic diversity in
HLA-B, it should be noted that this does not imply that we
should not expect some specific viruses to be targeted by
some HLA-B allotypes as it is, indeed, the case for HIV
(Carrington et al. 1999; Gao et al. 2010; Stephen et al. 2001).
When using the sequence-based measures of diversity
(JTT), the correlation between genetic diversity and
pathogen richness was less pronounced. One possible
explanation is that the weighting given by the JTT matrix to
R2=4.8%**
R2=4.3%** R2=1.6% ns
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Fig. 4 Relationship between
genetic diversity at MHC class I
genes [residuals from the
regression against the distance
from Sub-Saharan Africa for
heterozygosity (a)–(c) and JTT
diversity (d)–(f)] versus total
endemic pathogen richness
(number of pathogens present in
each country where a population
was sampled). R2 represents the
proportion of explained
variance. ***P<0.001;
**P<0.01; *P<0.05. ns
non-significant. Significant
relationships are highlighted in
bold
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amino acid changes (based on the likelihood of such changes
from a large database of proteins) might not be a good
predictor of function for the MHC molecules. If this was the
case, the extra information provided by the JTTmeasure could
simply correspond to noise being added to the information
provided by the allotype frequencies, thus deteriorating the
genuine signal detected by heterozygosity.
By compiling and analysing a large database of MHC
allotype frequencies from human populations worldwide,
we were able to confirm and expand previous findings
(Prugnolle et al. 2005b). Diversity at all three class I MHC
loci was shown to be affected both by ancient demography
and pathogen-driven selection. Furthermore, the use of
sequence-based measures of diversity provides evidence for
past coevolution between HLA-C and KIR.
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